1

Receptos

Receptos
Leadership team

Fred Aslan (Founder)

Hugh Rosen (Founder)

Kristina Burow (Founder)

Products/ Services
Biopharma, Biotechnology, Health Care
Number of Employees
1,000 - 20,000
Headquarters
San Diego, California, United States
Established
2007
Company Registration
SEC CIK number: 0001463729
Net Income
1B - 20B
Revenue
Above - 1B
Traded as
NASDAQ:RCPT
Social Media
Overview
Location
Summary
Receptos, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing treatments for immune diseases and cancer.
History

Receptos, Inc. was founded in April 2009. The company has since focused its research and development efforts on the treatment of immune diseases and cancer through targeting the sphingosine-1-phosphate (S1P) receptor modulators. Receptos’ clinical compounds target autoimmune diseases and inflammatory conditions, including multiple sclerosis and ulcerative colitis.

Mission
Our mission is to discover, develop and commercialize novel treatments for immune-mediated diseases and cancer.
Vision
We envision a world in which people affected by immune-mediated diseases and cancer have access to safe, effective and affordable treatments.
Key Team

Marcus F. Boehm (Founder)

Robert J. Peach (Founder)

Raymond E. Stevens (Founder)

William Rastetter (Founder)

Recognition and Awards
Receptoz has won several awards and recognitions including the 2016 Fierce 15 award honoring its innovative development of therapies for multiple sclerosis and ulcerative colitis.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Receptos
Leadership team

Fred Aslan (Founder)

Hugh Rosen (Founder)

Kristina Burow (Founder)

Products/ Services
Biopharma, Biotechnology, Health Care
Number of Employees
1,000 - 20,000
Headquarters
San Diego, California, United States
Established
2007
Company Registration
SEC CIK number: 0001463729
Net Income
1B - 20B
Revenue
Above - 1B
Traded as
NASDAQ:RCPT
Social Media